<DOC>
	<DOC>NCT00387257</DOC>
	<brief_summary>The purpose of this study is to compare the effects of repeat doses of SB-659032 with placebo on platelet aggregation in subjects.</brief_summary>
	<brief_title>Effect Of Rilapladib (SB-659032) On Platelet Aggregation</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Subjects with QTc &lt; 450 msec as measured at screening. History of asthma. Smokers.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>platelet aggregation</keyword>
	<keyword>SB-659032</keyword>
	<keyword>rilapladib</keyword>
</DOC>